Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $525.0M
Cost of Revenue $339.2M
Gross Profit $185.8M
Gross Margin 35.4%
Operating Expenses
Research & Development $5.9M
SG&A Expense $112.5M
Operating Income $39.6M
Operating Margin 7.5%
Interest Expense $7.2M
Pretax Income $32.4M
Income Tax Expense $8.6M
Net Income $23.8M
Net Margin 4.5%
EPS (Basic) $0.28
EPS (Diluted) $0.28
Shares Outstanding (Basic) —
Shares Outstanding (Diluted) —
Dividends Per Share —
← Newer Page 3 of 3 Older →